Wound Architecture and Functional Outcome After Cataract Surgery With Manual vs.Femtosecond Laser Assisted Procedures (CATALYS)

February 24, 2021 updated by: Dr. Paul Harasymowycz, Maisonneuve-Rosemont Hospital

Wound Architecture and Functional Outcome After Cataract Surgery With Manual vs. Femtosecond Laser Assisted Procedures

This study is the long term analysis of two types of FSL 3-plane corneal wound profiles, namely CT1 and CT2 obtained after a FSL cataract surgery.

Study Overview

Status

Completed

Conditions

Detailed Description

Femtosecond laser cataract surgery offers several major advantages for wound construction, including high precision, repeatability and a large variety of corneal wound profiles. The aim of this study is the long term analysis of two types of FSL 3-plane corneal wound profiles, namely CT1 and CT2, CT2 being constructed with a reversed front corneal incision segment to ensure tigher wound closure and better corneal wound reapposition. The traditional manual wound performed with a standard keratome will be used as a reference. As FSL cataract surgery may be associated with a greater incidence of wound leaks at the end of surgery as compared to manual wound construction with keratomes, this study will also aim at determining wich clinical and OCT wound parameters are associated with a higher likelihood of wound leaks.

Study Type

Interventional

Enrollment (Actual)

1123

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H1V 1G5
        • Montreal Glaucoma Institut

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Consecutive cases of cataract surgery performed between January 2015 and june 2015 by a single surgeon (PH) at the clinique d'ophtalmologie Bellevue, using either the Catalys or a manual technique.
  • One eye per patient, the first eye
  • Uneventful cataract only

Exclusion Criteria:

  • Combined glaucoma filtering surgery
  • Any previous corneal surgery in this eye
  • Any pathology of the interior segment
  • Inflammatory eye disease of the interior segment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CT1

FLACS- Initial Wound parameters (CT1)

Sample size calculation based on woundleak incidence estimated from preliminary results:

  • For CT1 vs MT, we will only need 10 per group to have 80% power assuming a 1:1 ratio of CT to MT and 5% type 1 error.
  • For CT1 vs CT2, we will need 22 per group to have 80% power (assuming 60% wound leakage in CT1 and 20% wound leakage in CT2, a 1:1 ratio, and a 5% type 1 error rate)
  • A total of 253 patients are eligible for this study, 101 with FLACS and 152 with Manual Cataract Surgery. We thus expect that our study population will allow adequate analysis of the main outcome parameters proposed herein.
Catalys create a circular opening for accessing and removing the cataract.
Other Names:
  • ReLACS
Experimental: CT2

The revised profile CT2, consists of a wider anterior side cut angle (beveled corneal undercut) and a narrower posterior side cut angle compared to the initial CT1 profile. This new corneal incision profile is constructed to ensure a tigher wound closure and a better corneal wound reapposition.

The traditional manual wound performed with a standard keratome wil be used as a reference.

Catalys create a circular opening for accessing and removing the cataract.
Other Names:
  • ReLACS
Active Comparator: MT control group
Standard manual technique (MT)
Catalys create a circular opening for accessing and removing the cataract.
Other Names:
  • ReLACS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preservation of a physiological postoperative anatomy will be considered as a criterion of success
Time Frame: 2 Months
Change in corneal anatomy as measured by the difference between pre-and postoperative corneal profile on OCT images
2 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The absence or a lower incidence of wound leak will also be considered as a criterion of success
Time Frame: 2 Months
Presence or not of a wound leak necessitating a 10.0 Nylon to stop the leak
2 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Paul Harasymowycz, MD, Ciusss de L'Est de l'Île de Montréal

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2017

Primary Completion (Actual)

February 28, 2020

Study Completion (Actual)

October 1, 2020

Study Registration Dates

First Submitted

June 10, 2016

First Submitted That Met QC Criteria

March 27, 2017

First Posted (Actual)

March 31, 2017

Study Record Updates

Last Update Posted (Actual)

February 25, 2021

Last Update Submitted That Met QC Criteria

February 24, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • F11a-CEMTL-3355

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Publication of data and results in an Ophtalmology journal, conferences

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on Femtosecond cataract surgery

Subscribe